MedTrace Logo

Videoconferencing-based Focused Acceptance and Commitment Therapy for Parents of SHCN Children

NCT05803252 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2026-03-05

No results posted yet for this study

Summary

The purpose of the proposed non-randomized waitlist-controlled design study is to evaluate the feasibility, acceptability, and potential effectiveness of using a Videoconferencing-based Individual Focused Acceptance and Commitment Therapy (FACT) approach to enhance the mental well-being of parents of children with special healthcare needs (SHCN) over a three-month period after the intervention has taken place.

Conditions

Interventions

BEHAVIORAL

Focused Acceptance and Commitment Therapy

FACT aims to increase one's psychological flexibility so that one will not generate feelings of distress and suffering when confronted with painful life situations. The intervention of this study will follow the FACT principles laid out by Strosahl, Robinson and Gustavsson to increase parents' psychological flexibility. Three core processes influence one's psychological flexibility: awareness, openness, and engagement. The key objectives of each core process are: 1. Awareness: Able to experience the present moment, able to take perspective on self 2. Openness: Able to detach distressing private experiences and associated rules, able to take a non-judgemental, accepting stance towards painful material 3. Engagement: Exhibits strong connection with values, able to sustain values-consistent action

OTHER

Waitlist Control

The waitlist control group participants will commence their FACT intervention immediately after they complete their follow-up assessment.

Sponsors & Collaborators

  • Hong Kong Christian Service

    collaborator OTHER

  • Hong Kong Federation of Youth Groups

    collaborator UNKNOWN

  • Hong Kong Young Women's Christian Association

    collaborator OTHER

  • Yang Memorial Methodist Social Service

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2025-12-30
Completion
2026-02-28

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05803252 on ClinicalTrials.gov